Danaher Co. (NYSE:DHR) Receives $333.40 Consensus Target Price from Analysts

Danaher Co. (NYSE:DHRGet Rating) has received a consensus recommendation of “Buy” from the seventeen research firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $333.40.

A number of equities analysts have recently issued reports on the stock. Barclays dropped their price objective on shares of Danaher from $355.00 to $325.00 and set an “overweight” rating on the stock in a research note on Thursday, January 27th. Robert W. Baird decreased their target price on shares of Danaher from $340.00 to $334.00 in a research report on Friday, January 28th. Wells Fargo & Company decreased their target price on shares of Danaher from $350.00 to $330.00 and set an “overweight” rating for the company in a research report on Friday, January 28th. StockNews.com raised shares of Danaher from a “hold” rating to a “buy” rating in a research report on Thursday, March 24th. Finally, Sanford C. Bernstein started coverage on shares of Danaher in a research report on Monday, January 10th. They set an “outperform” rating and a $365.00 target price for the company.

In other Danaher news, EVP Joakim Weidemanis sold 20,508 shares of Danaher stock in a transaction dated Monday, January 31st. The stock was sold at an average price of $285.24, for a total transaction of $5,849,701.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Brian W. Ellis sold 5,365 shares of Danaher stock in a transaction dated Wednesday, February 2nd. The shares were sold at an average price of $293.99, for a total value of $1,577,256.35. The disclosure for this sale can be found here. 11.40% of the stock is currently owned by corporate insiders.

Several large investors have recently bought and sold shares of the company. BlackRock Inc. grew its position in shares of Danaher by 3.1% during the 3rd quarter. BlackRock Inc. now owns 45,621,495 shares of the conglomerate’s stock valued at $13,889,008,000 after acquiring an additional 1,360,659 shares during the period. Morgan Stanley grew its position in shares of Danaher by 4.6% during the 3rd quarter. Morgan Stanley now owns 14,362,364 shares of the conglomerate’s stock valued at $4,372,479,000 after acquiring an additional 635,346 shares during the period. Geode Capital Management LLC grew its position in shares of Danaher by 2.8% during the 4th quarter. Geode Capital Management LLC now owns 10,539,950 shares of the conglomerate’s stock valued at $3,457,729,000 after acquiring an additional 291,597 shares during the period. Bank of New York Mellon Corp grew its position in shares of Danaher by 1.0% during the 3rd quarter. Bank of New York Mellon Corp now owns 6,954,668 shares of the conglomerate’s stock valued at $2,117,282,000 after acquiring an additional 69,402 shares during the period. Finally, Norges Bank acquired a new stake in shares of Danaher during the 4th quarter valued at about $2,015,889,000. Hedge funds and other institutional investors own 82.84% of the company’s stock.

Shares of NYSE DHR traded down $8.17 during midday trading on Monday, reaching $291.12. 1,984,189 shares of the company’s stock traded hands, compared to its average volume of 2,987,355. The company has a quick ratio of 1.09, a current ratio of 1.43 and a debt-to-equity ratio of 0.53. The stock’s 50 day simple moving average is $280.17 and its 200-day simple moving average is $297.15. Danaher has a one year low of $231.09 and a one year high of $333.96. The company has a market cap of $208.25 billion, a price-to-earnings ratio of 33.77, a P/E/G ratio of 1.40 and a beta of 0.78.

Danaher (NYSE:DHRGet Rating) last released its quarterly earnings data on Thursday, January 27th. The conglomerate reported $2.69 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.19. Danaher had a net margin of 21.84% and a return on equity of 18.87%. The firm had revenue of $8.15 billion for the quarter, compared to the consensus estimate of $7.98 billion. During the same period last year, the firm earned $2.08 earnings per share. The company’s quarterly revenue was up 20.5% on a year-over-year basis. Equities analysts predict that Danaher will post 10.41 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 29th. Investors of record on Friday, March 25th will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 0.34%. The ex-dividend date of this dividend is Thursday, March 24th. This is a boost from Danaher’s previous quarterly dividend of $0.21. Danaher’s dividend payout ratio (DPR) is 11.60%.

About Danaher (Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Read More

Analyst Recommendations for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.